Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease.
Alzheimer disease (AD) is a chronic neurodegenerative disease that is characterized by progressive memory loss. Pathological markers of AD include neurofibrillary tangles, accumulation of amyloid-beta plaques, neuronal loss, and inflammation. The exact events that lead to the neuronal dysfunction and loss are not completely understood. However, pro-inflammatory cytokines, such as interleukin-1beta, interleukin-6, and tumor necrosis factor alpha, are increased in AD, along with gene expression of major histocompatibility complex (MHC) class II molecules and macrophage migration inhibitory factor (MIF). MHC class II molecules are found in microglia of the brain, while MIF is found in both microglia and neurons of the hypothalamus, hippocampus, and cortex. MIF is not only a lymphocyte mediator but also a pituitary factor with endocrine properties and can mediate phosphorylation of the extracellular signal-regulated kinase-1/2 MAP kinases pathway. In this study, we looked at CD74, an integral membrane protein that acts as both a chaperone for MHC class II molecules as well as a receptor binding site for MIF. CD74 was recently found to be increased in microglia in AD cases compared to age-matched controls, but has not been reported in neurons. In our analysis, immunohistochemistry revealed a significant increase in CD74 primarily in neurofibrillary tangles, amyloid-beta plaques, and microglia. This is the first finding to our knowledge that CD74 is increased in neurons of AD cases compared to age-matched control cases.
Bryan
Kathryn J
KJ
Department of Neurosciences, Case Western Reserve University, Cleveland Ohio, USA. gemma.casadesus@case.edu.
Zhu
Xiongwei
X
Harris
Peggy L
PL
Perry
George
G
Castellani
Rudy J
RJ
Smith
Mark A
MA
Casadesus
Gemma
G
J Biol Chem. 2002 Feb 15;277(7):4644-8
11733539
Mech Ageing Dev. 2001 Dec;123(1):39-46
11640950
Ann N Y Acad Sci. 2005 Jun;1052:201-9
16024763
Blood. 2006 Jun 15;107(12):4807-16
16484589
Biochem Biophys Res Commun. 2005 Dec 16;338(2):973-80
16286092
Lancet Neurol. 2004 Apr;3(4):219-26
15039034
Mol Biol Cell. 2005 Nov;16(11):5061-9
16107560
J Neurochem. 2006 Dec;99(5):1377-88
17064357
J Neurosci. 1999 Mar 15;19(6):1959-64
10066249
J Exp Med. 2003 Jun 2;197(11):1467-76
12782713
Biochim Biophys Acta. 2000 Jun 15;1479(1-2):91-102
11004532
Biochim Biophys Acta. 2002 Jan 30;1542(1-3):1-13
11853874
Immunol Cell Biol. 2001 Aug;79(4):368-75
11488984
Pharmacol Ther. 2006 Jul;111(1):99-113
16274748
J Neurochem. 2003 Jul;86(1):136-42
12807433
Neurosci Lett. 2000 Aug 25;290(2):125-8
10936693
J Biol Chem. 2007 Nov 9;282(45):32676-88
17767011
Neurology. 1999 Oct 22;53(7):1495-8
10534257
Neuroreport. 1999 Aug 2;10(11):2411-5
10439473
Neurobiol Aging. 2007 Dec;28(12):1821-33
17052803
Mol Neurodegener. 2006 Oct 03;1:14
17018137
J Neurosci. 1998 Apr 15;18(8):2801-7
9525997
Biochem Biophys Res Commun. 1996 Aug 14;225(2):474-8
8753786
J Neuroimmunol. 2007 Mar;184(1-2):69-91
17222916
Microbes Infect. 2002 Apr;4(4):449-60
11932196